Company Profile

Simulations Plus Inc
Profile last edited on: 5/13/22      CAGE: 4CKV8      UEI: MZN6WDBMXN24

Business Identifier: Developer of Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET).
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

42505 10th Street West
Lancaster, CA 93534
   (661) 723-7723
Location: Single
Congr. District: 23
County: Los Angeles

Public Profile

Simulations Plus, Inc. develops drug discovery and development software for mechanistic modeling and simulation, and machine-learning-based prediction of properties of molecules from their structure. The firm's products include GastroPlus that simulates the absorption, pharmacokinetics, and pharmacodynamics of drugs administered to humans and animals; DDDPlus, which simulates in vitro laboratory experiments to measure the rate of dissolution of the drug and additives in a dosage form; and MembranePlus that simulates laboratory experiments. The company also offers ADMET Predictor, a computer program that takes molecular structures as inputs and predicts their properties; MedChem Studio, a tool for data mining and designing new molecules; and MedChem Designer, a molecule drawing program or sketcher that integrates with MedChem Studio and ADMET Predictor. In addition, it is involved in the analysis and reporting of data collected during clinical trials of new and existing pharmaceutical products; and provision of consulting and contract research services to the pharmaceutical industry. The company operates in North America, South America, Europe, Japan, Australia, New Zealand, India, Singapore, and the Peoples Republic of China. Originally SBIR involved in 2007, firm re-entered the arena in 2021 - both projects continuing into Phase II

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Publicly Traded
Stock Info
IP Holdings

Awards Distribution by Agency

Key People / Management

  Thaddeus Henry Grasela Jr -- President

  Brett A Howell -- CEO, President & Director

  Shawn Oconnor -- CEO

  Walter S Woltosz -- Co-Founder, President and CEO

  Michael Bolger -- Chief Scientist

  Robert Fraczkiewicz

  Kyunghee Yang